Allergan Inc (AGN)

AGN (NYSE:Drugs)
$212.63
pos +0.45
+0.21%
Today's Range: 211.75 - 214.58 | AGN Avg Daily Volume: 3,185,200
Last Update: 12/19/14 - 4:01 PM EST
Volume: 3,357,565
YTD Performance: 87.28%
Open: $212.04
Previous Close: $212.18
52 Week Range: $100.46 - $214.66
Oustanding Shares: 297,898,630
Market Cap: 61,971,851,999
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 8 9 6
Moderate Buy 0 0 0 0
Hold 10 6 4 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 2.43 1.86 1.86 2.23
Latest Dividend: 0.05
Latest Dividend Yield: 0.10%
Dividend Ex-Date: 11/18/14
Price Earnings Ratio: 48.61
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
48.61 48.80 25.33
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
22.34% 114.17% 148.66%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.50 0.28 0.09
Net Income -10.30 258.69 5.26
EPS -9.80 0.00 0.00
Earnings for AGN:
EBITDA 2.07B
Revenue 6.30B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.81 $1.79 $6.29 $8.53
Number of Analysts 11 3 15 15
High Estimate $1.83 $1.84 $6.32 $8.65
Low Estimate $1.76 $1.76 $6.23 $7.70
Prior Year $1.35 $1.18 $4.77 $6.29
Growth Rate (Year over Year) 34.21% 51.69% 31.81% 35.60%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Herb Greenberg

 | Dec 9, 2014 | 11:10 AM EST

Has the pharmaceutical company really changed its strategy?

By

Jim Cramer

 | Dec 3, 2014 | 3:59 PM EST

An immense market rotation is happening.

By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

By

Jim Cramer

 | Nov 24, 2014 | 7:22 AM EST

I expect better from grown-up hedge fund managers.

By

Jim Cramer

 | Nov 18, 2014 | 4:04 PM EST

In this market, negativity is rarely being rewarded.

By

Jim Cramer

 | Nov 17, 2014 | 4:16 PM EST

The U.S. markets and economy are unique.

By

Brian Sozzi

 | Nov 17, 2014 | 1:00 PM EST

What this year-end flurry of deals highlights.

By

Jim Cramer

 | Nov 17, 2014 | 11:35 AM EST

The CEO of Allergan has created value for shareholders.

By

Antonia Oprita

 | Nov 17, 2014 | 5:30 AM EST

Japan falls back into a deep recession.

By

Jim Cramer

 | Nov 17, 2014 | 4:33 AM EST

There's a powerful collection of "what's working."

Ford is working on its third straight gain following two days of steep loses to start...
Market is holding on for gains for now but think Doug Kass is right and could see some dec...
I have a full blown article surrounding the U.S. Retail Sector coming out on soon, but f...
The dividend action is pretty quiet at the moment, but I wanted to point out for those gen...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.